查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2094533

周邊血管醫療設備市場－2026-2032年全球市場預測

Peripheral Vascular Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，周邊血管醫療設備市場將成長至 166 億美元，複合年成長率為 8.06%。

主要市場統計數據
基準年 2025 96.4億美元
預計年份：2026年 103.9億美元
預測年份 2032 166億美元
複合年成長率 (%) 8.06%

周邊血管醫療設備執行摘要

周邊血管醫療設備是診斷和治療周邊動脈疾病、靜脈血栓栓塞症、動脈瘤、動靜脈通路併發症以及除心臟和腦部以外的其他血管疾病的重要工具。其需求受多種臨床和公共衛生因素驅動，包括人口老化、糖尿病、肥胖、吸菸、慢性腎臟病狀硬化性血管疾病診斷數量的增加。全球衛生機構將心血管疾病列為全球首要死因，已發表的流行病學研究表明，周邊動脈疾病影響著全球數億人，因此對血管成形術用氣球、末梢用支架、斑塊動脈粥狀硬化斑塊切除術裝置、抗血栓除去裝置裝置、下腔靜脈濾器、血管移植物和血管內動脈瘤修復技術等醫療器械的需求持續存在。

周邊血管裝置領域的變革性變化

在導管輸送技術、血管內影像、低剖面器械平台、藥物釋放型技術和混合手術環境等技術的進步推動下，周邊血管器械市場正經歷著從開放性手術到血管內治療的轉變，從而重塑市場格局。治療策略正變得更加針對特定病變，器械的選擇受到血管直徑、鈣化程度、病變長度、血栓體積、膝下解剖結構以及糖尿病和腎病變等合併症的影響。

人工智慧對周邊血管裝置的累積影響

人工智慧 (AI) 正開始影響周邊血管疾病的各個方面，包括診斷、治療計劃、手術支援和後續觀察。 AI 驅動的影像工具可以幫助臨床醫生分割血管、量化狹窄程度並識別鈣化模式，從而提高 CT血管造影術、MRI血管造影術、超音波和手術成像觀察的一致性。這些功能在周邊動脈疾病中尤其重要，因為病變形態和血管血流分佈對治療策略有顯著影響。

關於周邊血管醫療設備的關鍵區域見解

由於中國、印度、日本、韓國、澳洲和東南亞等地的人口基數龐大，加之糖尿病盛行率不斷上升、人口老化以及醫院基礎設施的不斷完善，亞太地區在周圍血管器械市場的重要性日益凸顯。儘管該地區對周邊動脈疾病診斷、透析通路管理、靜脈介入治療和微創血管手術的需求強勁，但其應用程度取決於保險報銷系統的成熟度、醫生培訓水平、採購體係以及先進影像技術的普及程度。

關於周邊血管醫療設備的關鍵群體特定見解

北約成員國遍佈北美和歐洲的大部分地區，形成了一個擁有先進醫療保健體系、嚴格採購結構和嚴密監管的廣泛環境。雖然北約本身並非醫療保健市場結構，但成員國普遍共用著對醫療設備品質、供應鏈韌性、網路安全、緊急準備和醫療技術採購連續性的高標準，而所有這些對於用於緊急和計劃性血管治療的周邊血管醫療設備而言都日益重要。

來自主要國家關於周邊血管醫療設備的見解

在中國，隨著老化和糖尿病負擔的加重，血管介入治療能力正在迅速提升，相關政策重點在於推動國產化生產、醫院現代化以及提高先進醫療設備的可及性。美國擁有專業的血管照護體系、門診血管內治療中心、完善的醫保報銷機制以及積極運用真實世界數據（RWE），是周邊血管醫療設備應用最廣泛的地區之一。日本擁有極為完善的老年照護體系，對低創傷、高精準度的血管內治療技術需求旺盛，對品質要求極高。相較之下，印度在周邊動脈疾病和透析通路介入治療方面仍存在大量未滿足的需求，相關治療主要集中在私立醫院和三級醫療機構，且其開展取決於這些機構的經濟承受能力。

為周邊血管醫療設備領導企業提供的實用建議

產業領導企業應優先研發具有臨床差異化的器械，以應對複雜病變、鈣化血管、膝下疾病、靜脈阻塞、透析通路、血栓切除術以及長期植入性能等問題。產品開發應基於可靠的臨床終點指標，包括血管通暢率、目標病變血管重組、截肢率降低、安全性、易用性和生活品質 (QOL) 結果。

周邊血管醫療設備分析的調查方法

本執行摘要採用系統的二手資料調查方法編寫，所用資料檢驗的公共領域和機構認可的資訊來源。該方法包括對臨床指南、監管公告、公共衛生資料庫、同行評審文獻、疾病負擔報告、醫療設備安全更新、保險報銷參考資料以及醫療基礎設施指標的審查。資訊來源通常包括國家衛生組織、世界衛生組織、監管機構、醫學協會、臨床註冊機構和已收錄的醫學出版物。

結論：推廣實證周邊血管護理。

隨著醫療保健系統應對日益嚴重的周邊動脈疾病、糖尿病相關血管併發症、靜脈疾病、透析通路相關挑戰以及動脈瘤等疾病，周邊血管醫療設備已成為現代血管醫學的核心。該領域正透過微創血管內治療技術、改進的影像技術、藥物整合型醫療設備平台、複雜病變的治療以及對上市後證據日益成長的期望而不斷進步。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 周邊血管醫療設備市場：依產品分類

  • 氣球充氣裝置
  • 導管
    • 長周邊靜脈導管
    • 中線導管
    • 短周邊靜脈導管
  • 接枝
    • 生物移植
    • ePTFE 接枝
    • 聚酯接枝
  • 導管導引線
  • 下腔靜脈濾器
  • 安裝設備
  • 斑塊修飾裝置
  • 支架
    • 球囊擴張型支架
    • 自動擴張型支架
  • 血管閉合裝置

第8章 周邊血管醫療設備市場：依技術類型分類

  • 微創手術
    • 血管成形術
    • 支架置入術
  • 開放性手術
    • 心臟繞道手術
    • 切除術

第9章 周邊血管醫療設備市場：依材料類型分類

  • 金屬裝置
    • 鈷鉻合金
    • 鎳鈦諾
    • 不銹鋼
  • 非金屬裝置
    • 聚合物
    • 矽酮

第10章 周邊血管醫療設備市場：依適應症分類

  • 功能性周邊血管疾病
    • 慢性靜脈功能不全
    • 雷諾氏症
    • 靜脈曲張
  • 阻塞性周邊血管疾病
    • 動脈硬化
    • 比爾格氏症
    • 頸動脈疾病
    • 深層靜脈栓塞症
    • 淋巴水腫

第11章 周邊血管醫療設備市場：依病患類型分類

  • 成年人和老年人
    • 急性病
    • 慢性病
  • 兒童
    • 後天疾病
    • 先天性疾病

第12章 周邊血管醫療設備市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第13章 周邊血管醫療設備市場：依地區分類

  • 亞太地區
  • 歐洲
  • 北美洲
  • 拉丁美洲
  • 非洲
  • 中東

第14章 周邊血管醫療設備市場：依類別分類

  • NATO
  • G7
  • BRICS
  • EU
  • ASEAN
  • GCC

第15章 周邊血管醫療設備市場：依國家分類

  • 中國
  • 美國
  • 日本
  • 印度
  • 德國
  • 英國
  • 澳洲
  • 法國
  • 韓國
  • 義大利
  • 加拿大
  • 俄羅斯
  • 巴西
  • 墨西哥
  • 西班牙

第16章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • Abbott Laboratories
  • AngioDynamics, Inc.
  • Argon Medical Devices, Inc.
  • ASAHI INTECC CO., LTD
  • B. Braun SE
  • Baxter International Inc.
  • Becton, Dickinson and Company
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Cardinal Health, Inc.
  • Cook Group Incorporated
  • Esaote SpA
  • FUJIFILM Holdings Corporation
  • GE HealthCare
  • Kimal PLC
  • Koninklijke Philips NV
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Nipro Corporation
  • Penumbra, Inc.
  • Sahajanand Medical Technologies Limited
  • Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • Siemens Healthineers AG
  • Summa Therapeutics, LLC
  • Teleflex Incorporated
  • Terumo Corporation
  • WL Gore & Associates, Inc.
Product Code: MRR-374DB5A063C3

The Peripheral Vascular Devices Market is projected to grow by USD 16.60 billion at a CAGR of 8.06% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 9.64 billion
Estimated Year [2026] USD 10.39 billion
Forecast Year [2032] USD 16.60 billion
CAGR (%) 8.06%

Peripheral Vascular Devices Executive Summary

Peripheral vascular devices are critical tools used to diagnose and treat peripheral artery disease, venous thromboembolism, aneurysms, arteriovenous access complications, and other vascular conditions outside the heart and brain. Demand is supported by well-established clinical and public health drivers, including population aging, diabetes, obesity, smoking exposure, chronic kidney disease, and rising diagnosis of atherosclerotic vascular disease. Global health authorities identify cardiovascular disease as the leading cause of death worldwide, while published epidemiological studies report that peripheral artery disease affects hundreds of millions of people globally, creating a durable clinical need for angioplasty balloons, peripheral stents, atherectomy systems, thrombectomy devices, embolic protection devices, vena cava filters, vascular grafts, and endovascular aneurysm repair technologies.

The sector is moving toward less invasive, image-guided, and patient-specific vascular care. Hospitals, ambulatory surgical centers, and specialized vascular centers increasingly prioritize devices that improve vessel patency, reduce restenosis, shorten procedure times, enable limb salvage, and support same-day or reduced-stay care pathways. At the same time, regulatory expectations, post-market surveillance, device traceability, and clinical evidence generation are becoming more rigorous, especially for drug-coated devices, implantable stents, and long-term vascular implants. For industry participants, success increasingly depends on clinical differentiation, physician training, reimbursement alignment, supply chain reliability, and evidence that devices improve outcomes in real-world vascular populations.

Transformative Shifts in the Peripheral Vascular Devices Landscape

The peripheral vascular devices landscape is being reshaped by the transition from open surgery to endovascular intervention, supported by advances in catheter-based delivery, intravascular imaging, low-profile device platforms, drug-eluting technologies, and hybrid operating environments. Treatment strategies are becoming more lesion-specific, with device selection influenced by vessel size, calcification, lesion length, thrombus burden, below-the-knee anatomy, and comorbidities such as diabetes and renal disease.

A major transformative shift is the growing emphasis on limb preservation and early intervention for peripheral artery disease. Clinical pathways increasingly integrate vascular imaging, wound care, diabetic foot management, and revascularization planning to reduce major amputations. Device innovation is also focusing on complex disease segments, including chronic total occlusions, heavily calcified vessels, venous obstruction, dialysis access maintenance, and endovascular repair of peripheral aneurysms.

Regulatory and clinical scrutiny is also changing product development. Drug-coated balloons and drug-eluting stents remain important technologies, but long-term safety data, patient-level evidence, and transparent adverse event monitoring are now central to adoption decisions. Hospitals are also evaluating total episode-of-care impact, including device durability, reintervention rates, contrast use, radiation exposure, and procedure efficiency. These shifts favor manufacturers and care providers that can combine high-quality clinical data with practical workflow integration and physician education.

Cumulative Impact of AI on Peripheral Vascular Devices

Artificial intelligence is beginning to influence peripheral vascular care across diagnosis, planning, procedure support, and follow-up. AI-enabled imaging tools can assist clinicians in segmenting vessels, quantifying stenosis, identifying calcification patterns, and improving consistency in interpretation across computed tomography angiography, magnetic resonance angiography, duplex ultrasound, and intraprocedural imaging. These capabilities are particularly relevant in peripheral artery disease, where lesion morphology and vessel runoff strongly affect treatment strategy.

In procedural environments, AI has the potential to support device sizing, access planning, navigation, radiation reduction, and contrast optimization. Predictive analytics may help stratify patients by risk of restenosis, thrombosis, wound non-healing, or reintervention, enabling more personalized follow-up schedules and therapy decisions. AI can also strengthen post-market surveillance by detecting device-related safety signals from registries, electronic health records, and real-world evidence databases.

However, cumulative impact depends on validated clinical performance, data quality, interoperability, cybersecurity, and equitable representation of diverse patient populations. AI systems used in vascular care must be evaluated against clinically meaningful endpoints such as diagnostic accuracy, procedural efficiency, limb outcomes, adverse event reduction, and durability of revascularization. For device developers, the strongest opportunities lie in combining AI with imaging, robotics, remote monitoring, and evidence generation while maintaining compliance with evolving medical device software regulations.

Key Regional Insights for Peripheral Vascular Devices

Asia-Pacific is becoming increasingly important for peripheral vascular devices due to a large population base, rising diabetes prevalence, aging demographics, and expanding hospital infrastructure across China, India, Japan, South Korea, Australia, and Southeast Asia. The region shows strong need for peripheral artery disease diagnosis, dialysis access management, venous intervention, and minimally invasive vascular procedures, although adoption levels vary by reimbursement maturity, physician training, procurement systems, and access to advanced imaging.

Europe combines advanced vascular care infrastructure with strong regulatory requirements under the European medical device framework. Western European countries have broad access to endovascular treatment, peripheral stents, angioplasty balloons, vascular grafts, and endovascular aneurysm repair systems, while adoption patterns differ across Central and Eastern Europe depending on reimbursement, clinical capacity, and procurement funding. Clinical registries, health technology assessment, and evidence-based purchasing have significant influence on device adoption and post-market follow-up.

North America remains a highly advanced environment for peripheral vascular intervention, supported by established vascular surgery, interventional radiology, and interventional cardiology networks; robust use of endovascular techniques; and structured regulatory oversight. The United States and Canada emphasize clinical evidence, reimbursement documentation, outpatient procedure efficiency, device traceability, and real-world safety monitoring, particularly for implantable and drug-coated technologies.

Latin America shows expanding demand for peripheral vascular devices as urban hospital systems modernize and chronic disease burdens rise. Brazil and Mexico are central to regional adoption, with growth in endovascular capabilities shaped by public-private healthcare differences, procurement processes, specialist availability, and affordability constraints. Across the region, access to complex limb salvage procedures, thrombectomy devices, and advanced vascular imaging remains concentrated in higher-capacity urban centers.

Africa faces a dual challenge of rising noncommunicable vascular disease and uneven access to specialized vascular intervention. Urban referral centers increasingly provide endovascular care, but device availability, diagnostic access, trained specialists, and affordability remain key limitations. The Middle East is investing in tertiary care, vascular centers, and advanced imaging, with demand linked to diabetes, obesity, smoking, and cardiovascular risk factors. GCC countries are particularly active in adopting advanced medical technologies, while access varies across the broader region.

Key Group Insights for Peripheral Vascular Devices

NATO countries span North America and much of Europe, creating a broad environment of advanced healthcare systems, procurement discipline, and regulatory scrutiny. While NATO itself is not a healthcare market structure, member countries commonly share high standards for device quality, supply chain resilience, cybersecurity, emergency preparedness, and continuity of medical technology procurement, all of which are increasingly relevant for peripheral vascular devices used in urgent and elective vascular care.

G7 countries represent mature and evidence-driven environments for peripheral vascular devices, with high procedural sophistication, strong clinical guideline influence, and emphasis on quality outcomes. These countries typically prioritize safety, durability, physician training, reimbursement-supported innovation, and post-market evidence for peripheral stents, drug-coated balloons, vascular grafts, thrombectomy systems, and endovascular repair technologies.

BRICS countries reflect diverse but clinically significant demand drivers. China and India have large patient pools and expanding vascular infrastructure, Brazil has a growing endovascular base, Russia maintains demand through major urban centers, and South Africa serves as an important advanced-care hub within the African context. Access differences, pricing pressure, regulatory localization, and public-private healthcare variation influence device strategy across the group.

The European Union is shaped by stringent medical device regulation, health technology assessment, and growing demand for real-world clinical evidence. Peripheral vascular device adoption depends heavily on conformity assessment, post-market clinical follow-up, reimbursement rules, registry participation, and demonstrated value in reducing complications, repeat interventions, and long-term vascular care costs.

ASEAN countries are expanding access to peripheral vascular devices through hospital modernization, rising private healthcare participation, and increasing recognition of diabetes-related vascular complications. Adoption is strongest in major urban centers, where endovascular expertise, imaging infrastructure, and international clinical training are more available, while rural access remains uneven and affordability remains central to procurement decisions.

The GCC demonstrates strong potential for advanced vascular technologies due to high healthcare investment, elevated cardiometabolic disease burden, and government initiatives to expand specialized care. Demand is supported by tertiary hospitals and medical city developments, although procurement standardization, local clinical capacity building, and long-term follow-up systems remain important for sustainable adoption.

Key Country Insights for Peripheral Vascular Devices

China is rapidly expanding vascular intervention capacity as its aging population and diabetes burden increase, with policy attention on local manufacturing, hospital modernization, and broader access to advanced devices. The United States is one of the most procedure-intensive environments for peripheral vascular devices, supported by specialized vascular practices, outpatient endovascular centers, advanced reimbursement pathways, and strong use of real-world evidence. Japan has a highly advanced aging-care environment with strong demand for low-profile, precision endovascular technologies and strict quality expectations, while India has substantial unmet need for peripheral artery disease and dialysis access intervention, with adoption concentrated in private and tertiary centers and shaped by affordability.

Germany is a major European center for advanced endovascular practice, supported by hospital capacity, specialist expertise, and rigorous regulatory compliance. The United Kingdom maintains structured vascular networks and guideline-driven care, with strong focus on limb salvage and efficient use of public healthcare resources. Australia combines high clinical standards, centralized reimbursement evaluation, and advanced specialist care, while France combines strong clinical infrastructure with reimbursement evaluation and evidence requirements. South Korea has sophisticated hospital infrastructure, rapid adoption of minimally invasive technologies, and strong digital health readiness, supporting advanced peripheral vascular treatment pathways.

Italy and Spain show significant adoption of minimally invasive vascular procedures across regional health systems, with variation in procurement and access. Canada emphasizes publicly funded care, evidence-based adoption, and regional access planning, with demand driven by aging and chronic disease. Russia has demand concentrated in major metropolitan hospitals, where advanced endovascular capabilities coexist with regional disparities. Brazil leads much of Latin America in vascular procedure capability, with advanced centers in large urban regions and ongoing demand from diabetes, chronic kidney disease, and cardiovascular risk factors. Mexico is expanding vascular intervention capacity in major cities, although access is influenced by payer segmentation and hospital infrastructure.

Actionable Recommendations for Peripheral Vascular Device Leaders

Industry leaders should prioritize clinically differentiated devices that address complex lesions, calcified vessels, below-the-knee disease, venous obstruction, dialysis access, thrombectomy, and long-term implant performance. Product development should be anchored in robust clinical endpoints, including patency, target lesion revascularization, amputation reduction, safety, usability, and quality-of-life outcomes.

Organizations should strengthen real-world evidence capabilities through registries, post-market clinical follow-up, and interoperable data systems that support regulatory compliance and payer confidence. Partnerships with hospitals and physician societies should focus on training, case planning, imaging optimization, and safe adoption of advanced techniques. In emerging markets, strategies should balance affordability, local regulatory requirements, distributor quality, and specialist education.

Supply chain resilience is increasingly important for vascular devices, especially implantable stents, balloons, guidewires, catheters, grafts, and procedure kits. Leaders should also invest in AI-enabled imaging integration, device traceability, cybersecurity, and sustainability in packaging and sterilization. Commercial success will depend on proving value not only through device performance but also through workflow efficiency, reduced complications, and better patient outcomes.

Research Methodology for Peripheral Vascular Devices Analysis

This executive summary is developed through a structured secondary research methodology using verified public-domain and institutionally recognized sources. The approach includes review of clinical guidelines, regulatory communications, public health databases, peer-reviewed literature, disease burden reports, medical device safety updates, reimbursement references, and healthcare infrastructure indicators. Sources typically include national health agencies, international health organizations, regulatory authorities, professional medical societies, clinical registries, and indexed medical publications.

The analysis focuses on qualitative market intelligence rather than market sizing or forecasting. Data points are evaluated for credibility, recency, consistency, and relevance to peripheral vascular devices, including angioplasty balloons, stents, atherectomy systems, thrombectomy devices, embolization devices, vascular grafts, vena cava filters, and endovascular repair systems. Regional, group, and country insights are synthesized by assessing disease burden, healthcare access, regulatory environment, reimbursement maturity, clinical infrastructure, physician expertise, and technology adoption patterns.

To ensure reliability, findings are triangulated across multiple source categories and interpreted in the context of current vascular care pathways. The methodology avoids unsupported claims and does not rely on speculative estimates, market share assumptions, or forward-looking market forecasts.

Conclusion: Advancing Evidence-Based Peripheral Vascular Care

Peripheral vascular devices are positioned at the center of modern vascular care as healthcare systems respond to the growing burden of peripheral artery disease, diabetes-related vascular complications, venous disease, dialysis access challenges, and aneurysmal conditions. The field is advancing through minimally invasive endovascular techniques, improved imaging, drug-based device platforms, complex lesion solutions, and stronger post-market evidence expectations.

Regional adoption differs significantly, with mature healthcare systems emphasizing outcomes, safety, and reimbursement value, while emerging regions focus on access expansion, affordability, infrastructure, and workforce development. Artificial intelligence, real-world evidence, and integrated care pathways are set to play increasingly important roles in diagnosis, procedural planning, surveillance, and patient follow-up.

For stakeholders across the peripheral vascular devices ecosystem, the strategic priority is clear: deliver clinically validated, workflow-compatible, and economically defensible technologies that improve vascular outcomes and expand access to high-quality care. Organizations that align innovation with evidence, training, regulatory rigor, and regional healthcare realities will be best positioned to strengthen their role in the evolving vascular intervention landscape.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Peripheral Vascular Devices Market, by Product

  • 7.1. Introduction
  • 7.2. Balloon Inflation Devices
  • 7.3. Catheters
    • 7.3.1. Long Peripheral Intravenous Catheters
    • 7.3.2. Midline Catheters
    • 7.3.3. Short Peripheral Intravenous Catheter
  • 7.4. Grafts
    • 7.4.1. Biological Grafts
    • 7.4.2. ePTFE Grafts
    • 7.4.3. Polyester Grafts
  • 7.5. Guidewires
  • 7.6. Inferior Vena Cava Filters
  • 7.7. Introducers
  • 7.8. Plaque Modification Devices
  • 7.9. Stents
    • 7.9.1. Balloon-Expandable Stents
    • 7.9.2. Self-Expanding Stents
  • 7.10. Vascular Closure Devices

8. Peripheral Vascular Devices Market, by Technology Type

  • 8.1. Introduction
  • 8.2. Minimally Invasive Surgeries
    • 8.2.1. Angioplasty
    • 8.2.2. Stenting
  • 8.3. Open Surgery
    • 8.3.1. Bypass Surgery
    • 8.3.2. Endarterectomy

9. Peripheral Vascular Devices Market, by Material Type

  • 9.1. Introduction
  • 9.2. Metal Devices
    • 9.2.1. Cobalt Chromium
    • 9.2.2. Nitinol
    • 9.2.3. Stainless Steel
  • 9.3. Non-Metal Devices
    • 9.3.1. Polymer
    • 9.3.2. Silicone

10. Peripheral Vascular Devices Market, by Indication

  • 10.1. Introduction
  • 10.2. Functional Peripheral Vascular Disease
    • 10.2.1. Chronic Venous Insufficiency
    • 10.2.2. Raynaud's Disease
    • 10.2.3. Varicose Veins
  • 10.3. Occlusive Peripheral Vascular Disease
    • 10.3.1. Atherosclerosis
    • 10.3.2. Buerger's Disease
    • 10.3.3. Carotid Artery Disease
    • 10.3.4. Deep Vein Thrombosis
    • 10.3.5. Lymphedema

11. Peripheral Vascular Devices Market, by Patient Types

  • 11.1. Introduction
  • 11.2. Adult & Geriatric
    • 11.2.1. Acute Conditions
    • 11.2.2. Chronic Conditions
  • 11.3. Pediatric
    • 11.3.1. Acquired Conditions
    • 11.3.2. Congenital Conditions

12. Peripheral Vascular Devices Market, by End-User

  • 12.1. Introduction
  • 12.2. Ambulatory Surgical Centers
  • 12.3. Clinics
  • 12.4. Hospitals

13. Peripheral Vascular Devices Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. Europe
  • 13.3. North America
  • 13.4. Latin America
  • 13.5. Africa
  • 13.6. Middle East

14. Peripheral Vascular Devices Market, by Group

  • 14.1. NATO
  • 14.2. G7
  • 14.3. BRICS
  • 14.4. European Union
  • 14.5. ASEAN
  • 14.6. GCC

15. Peripheral Vascular Devices Market, by Country

  • 15.1. China
  • 15.2. United States
  • 15.3. Japan
  • 15.4. India
  • 15.5. Germany
  • 15.6. United Kingdom
  • 15.7. Australia
  • 15.8. France
  • 15.9. South Korea
  • 15.10. Italy
  • 15.11. Canada
  • 15.12. Russia
  • 15.13. Brazil
  • 15.14. Mexico
  • 15.15. Spain

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2025
  • 16.2. FPNV Positioning Matrix, 2025
  • 16.3. Market Concentration Analysis, 2025
    • 16.3.1. Concentration Ratio (CR)
    • 16.3.2. Herfindahl Hirschman Index (HHI)
  • 16.4. Recent Developments & Impact Analysis, 2025
  • 16.5. Product Portfolio Analysis, 2025
  • 16.6. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. Abbott Laboratories
  • 17.2. AngioDynamics, Inc.
  • 17.3. Argon Medical Devices, Inc.
  • 17.4. ASAHI INTECC CO., LTD
  • 17.5. B. Braun SE
  • 17.6. Baxter International Inc.
  • 17.7. Becton, Dickinson and Company
  • 17.8. BIOTRONIK SE & Co. KG
  • 17.9. Boston Scientific Corporation
  • 17.10. Cardinal Health, Inc.
  • 17.11. Cook Group Incorporated
  • 17.12. Esaote S.p.A.
  • 17.13. FUJIFILM Holdings Corporation
  • 17.14. GE HealthCare
  • 17.15. Kimal PLC
  • 17.16. Koninklijke Philips N.V.
  • 17.17. Lepu Medical Technology (Beijing) Co., Ltd.
  • 17.18. Medtronic PLC
  • 17.19. Merit Medical Systems, Inc.
  • 17.20. Nipro Corporation
  • 17.21. Penumbra, Inc.
  • 17.22. Sahajanand Medical Technologies Limited
  • 17.23. Shockwave Medical, Inc. by Johnson & Johnson Services, Inc.
  • 17.24. Siemens Healthineers AG
  • 17.25. Summa Therapeutics, LLC
  • 17.26. Teleflex Incorporated
  • 17.27. Terumo Corporation
  • 17.28. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 25. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL BALLOON INFLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL BALLOON INFLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BALLOON INFLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL LONG PERIPHERAL INTRAVENOUS CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL LONG PERIPHERAL INTRAVENOUS CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL LONG PERIPHERAL INTRAVENOUS CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MIDLINE CATHETERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MIDLINE CATHETERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MIDLINE CATHETERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL SHORT PERIPHERAL INTRAVENOUS CATHETER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL EPTFE GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL EPTFE GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL EPTFE GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL POLYESTER GRAFTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL POLYESTER GRAFTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL POLYESTER GRAFTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL GUIDEWIRES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL GUIDEWIRES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL GUIDEWIRES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL INFERIOR VENA CAVA FILTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL INFERIOR VENA CAVA FILTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL INFERIOR VENA CAVA FILTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL INTRODUCERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL INTRODUCERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL INTRODUCERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PLAQUE MODIFICATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLAQUE MODIFICATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PLAQUE MODIFICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BALLOON-EXPANDABLE STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL SELF-EXPANDING STENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VASCULAR CLOSURE DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL MINIMALLY INVASIVE SURGERIES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ANGIOPLASTY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ANGIOPLASTY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL ANGIOPLASTY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STENTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL STENTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL STENTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL OPEN SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL OPEN SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL OPEN SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL BYPASS SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL BYPASS SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL BYPASS SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL ENDARTERECTOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL ENDARTERECTOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL ENDARTERECTOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL METAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL METAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL METAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL COBALT CHROMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL COBALT CHROMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL COBALT CHROMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL NITINOL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL NITINOL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL NITINOL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL STAINLESS STEEL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL STAINLESS STEEL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL STAINLESS STEEL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL NON-METAL DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL NON-METAL DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL NON-METAL DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL POLYMER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL POLYMER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL POLYMER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SILICONE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SILICONE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SILICONE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL FUNCTIONAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL FUNCTIONAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL FUNCTIONAL PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL CHRONIC VENOUS INSUFFICIENCY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL CHRONIC VENOUS INSUFFICIENCY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL CHRONIC VENOUS INSUFFICIENCY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL RAYNAUD'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL RAYNAUD'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL RAYNAUD'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VARICOSE VEINS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VARICOSE VEINS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VARICOSE VEINS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL OCCLUSIVE PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL OCCLUSIVE PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL OCCLUSIVE PERIPHERAL VASCULAR DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL ATHEROSCLEROSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL ATHEROSCLEROSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL ATHEROSCLEROSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL BUERGER'S DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL BUERGER'S DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BUERGER'S DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL CAROTID ARTERY DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL CAROTID ARTERY DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL CAROTID ARTERY DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL DEEP VEIN THROMBOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL DEEP VEIN THROMBOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL DEEP VEIN THROMBOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL LYMPHEDEMA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL LYMPHEDEMA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL LYMPHEDEMA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL ADULT & GERIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL ADULT & GERIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL ADULT & GERIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL ACUTE CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ACUTE CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL ACUTE CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL CHRONIC CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL CHRONIC CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL CHRONIC CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL ACQUIRED CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL ACQUIRED CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL ACQUIRED CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL CONGENITAL CONDITIONS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL CONGENITAL CONDITIONS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL CONGENITAL CONDITIONS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 173. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 174. ASIA-PACIFIC PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 193. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 194. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 195. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 196. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 197. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 198. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 200. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 201. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 206. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 207. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 208. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 209. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 210. NORTH AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 211. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 213. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 214. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 215. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 216. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 218. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 219. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 220. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 223. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 224. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 225. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 226. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 227. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 228. LATIN AMERICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 233. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 234. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 236. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 237. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 238. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 241. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 242. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 243. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 244. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 245. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 246. AFRICA PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 247. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 248. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 249. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 250. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 251. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 252. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 253. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 254. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 255. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 256. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 259. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 260. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 261. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 262. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 263. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 264. MIDDLE EAST PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 267. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 269. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 270. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 271. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 273. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 274. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 275. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 276. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 278. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 279. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 281. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 282. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 283. NATO PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 284. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 285. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 286. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 287. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 288. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 289. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 291. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 292. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 296. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 297. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 298. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 299. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 300. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 301. G7 PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 302. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 303. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 304. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 305. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 306. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 307. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 309. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 310. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 311. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 312. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 313. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 314. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 315. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 316. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 317. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 318. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 319. BRICS PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 320. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 321. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 322. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 323. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 324. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 325. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 326. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MINIMALLY INVASIVE SURGERIES, 2018-2032 (USD MILLION)
  • TABLE 327. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OPEN SURGERY, 2018-2032 (USD MILLION)
  • TABLE 328. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 330. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY NON-METAL DEVICES, 2018-2032 (USD MILLION)
  • TABLE 331. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 332. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY FUNCTIONAL PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 333. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY OCCLUSIVE PERIPHERAL VASCULAR DISEASE, 2018-2032 (USD MILLION)
  • TABLE 334. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PATIENT TYPES, 2018-2032 (USD MILLION)
  • TABLE 335. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY ADULT & GERIATRIC, 2018-2032 (USD MILLION)
  • TABLE 336. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PEDIATRIC, 2018-2032 (USD MILLION)
  • TABLE 337. EUROPEAN UNION PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 338. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 339. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 340. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY CATHETERS, 2018-2032 (USD MILLION)
  • TABLE 341. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY GRAFTS, 2018-2032 (USD MILLION)
  • TABLE 342. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY STENTS, 2018-2032 (USD MILLION)
  • TABLE 343. ASEAN PERIPHERAL VASCULAR DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)

T